about
Fabrication of poly (ϵ-caprolactone) microfiber scaffolds with varying topography and mechanical properties for stem cell-based tissue engineering applicationsTwo-component protein-engineered physical hydrogels for cell encapsulationBiomaterial design strategies for the treatment of spinal cord injuries.The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats.Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds.Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.Nanofiber matrices promote the neuronal differentiation of human embryonic stem cell-derived neural precursors in vitro.Intra-Spinal Bone Marrow Mononuclear Cells Transplantation Inhibits the Expression of Nuclear Factor-κB in Acute Transection Spinal Cord Injury in Rats.Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriersPositively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in RatThe differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages.Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.Regenerative medicine for the treatment of spinal cord injury: more than just promises?Carriers in cell-based therapies for neurological disorders.Gene therapy strategies for the treatment of spinal cord injury.Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres.[18F]-FBEM, a tracer targeting cell-surface protein thiols for cell trafficking imaging.Novel magnetic fibrin hydrogel scaffolds containing thrombin and growth factors conjugated iron oxide nanoparticles for tissue engineering.Chondroitinase ABC plus bone marrow mesenchymal stem cells for repair of spinal cord injuryDifferentiation of embryonic stem cells to cardiomyocytes on electrospun nanofibrous substrates.Protection of bone marrow, mononuclear, and CD34+ cells by enclosing within the biochemical compound solution during and after transplantation.Noninvasive bioluminescence imaging of olfactory ensheathing glia and schwann cells following transplantation into the lesioned rat spinal cord.Synergistic effect of neural stem cells and olfactory ensheathing cells on repair of adult rat spinal cord injury.Forever young: how to control the elongation, differentiation, and proliferation of cells using nanotechnology.Mesoporous silica nanoparticle-based substrates for cell directed delivery of Notch signalling modulators to control myoblast differentiation.BMSCs promote the differentiation of NSCs into oligodendrocytes via mediating Id2 and Olig expression through BMP/Smad signaling pathway
P2860
Q29391984-6972A387-5C20-41D4-8D45-6C96CF56C457Q30492276-4F21DE83-790C-4E5A-A866-F1D9104B3B12Q34076638-0DBA6F39-A112-4E22-8D68-E26A93429141Q34199629-D47FBA6B-FE89-49C2-AF51-3FD362787722Q34312191-50F4CDC1-F838-4575-9354-BAD98BC27B2AQ34482943-38508D98-4E8A-4E54-88DF-D1F152E6D56AQ34599726-59AE50AC-2DCC-4EBD-A529-B85CB6E9BD29Q34749818-8CF4AF51-E129-4654-9B38-102492B89A7DQ35855697-D958DFB8-6571-447E-B324-4EFEEB324038Q35865332-3D4CF797-310B-4EC6-8BBB-81140F5758BDQ37029717-36CF5C2E-6503-4C1A-8F95-4C78C37AE71DQ37202715-1FBAB160-29B4-404A-9CAD-39F3750FC9F7Q38005938-1D263285-845C-4D01-B2E0-AADC01BB82EEQ38026986-54408D1A-D8C3-431C-963B-47ADEFA851CDQ38220613-C4367461-2152-4C5B-BE48-F478FAE63ABCQ38226668-892D1DA4-423E-4B0E-ADF1-16ED0E97968DQ38897951-5B8420B6-0F58-4257-BC4B-887AD50F65A1Q39143436-A67FA523-F50F-496A-B9E3-29D32E124CE0Q39640609-EF0EA8F2-12D1-497F-971E-DA9FC9B68550Q42134842-34E5DA8C-E79A-4884-A7AE-5B554C976A77Q45764735-11BE157B-7334-40E6-92A0-5B9E963EE059Q47889954-8F74D582-7CB9-4F27-88A4-89C19AA1A54CQ47980734-F0079360-E5B5-436D-9A78-2B6A36ED9448Q48210520-F20522D4-4B0B-4994-864E-C8136AE839EAQ48365611-707D8436-8F80-4117-AFF0-4B7537D63D49Q53658494-B09E3F22-1991-4171-BB6D-09C94DE8F2A5Q58707994-08125E5F-06A6-400A-B74B-DE2C9AE76F08
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cell therapy for spinal cord regeneration
@ast
Cell therapy for spinal cord regeneration
@en
type
label
Cell therapy for spinal cord regeneration
@ast
Cell therapy for spinal cord regeneration
@en
prefLabel
Cell therapy for spinal cord regeneration
@ast
Cell therapy for spinal cord regeneration
@en
P2860
P1476
Cell therapy for spinal cord regeneration
@en
P2093
Shelly E Sakiyama-Elbert
P2860
P304
P356
10.1016/J.ADDR.2007.08.028
P407
P577
2007-10-05T00:00:00Z